Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLK vs GSK✓SelectedUSD · GSKXLK vs GSK performance historyLatest closeAs of+0.34%11/18
Stock and ETF performance explorer

XLK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+80.0%
GSK return
+56.0%
Excess return
+24.0%
Maximum drawdown
-25.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-1.3%+1.7%+0.3%
7D-6.1%-3.1%-2.9%-6.1%
30D-11.9%-0.9%-11.0%-11.9%
3M-11.6%-4.2%-7.5%-11.6%
6M-5.8%-1.6%-4.2%-5.9%
YTD+14.2%+2.6%+11.6%+13.7%
1Y+18.0%+6.2%+11.8%+17.3%
All+80.0%+56.0%+24.0%+77.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling